US 12,303,667 B2
Adjusting insulin delivery rates
Lane Desborough, Thousand Oaks, CA (US); and Bryan Mazlish, Palo Alto, CA (US)
Assigned to Insulet Corporation, Acton, MA (US)
Filed by Insulet Corporation, Acton, MA (US)
Filed on Nov. 16, 2020, as Appl. No. 16/949,819.
Application 16/949,819 is a continuation of application No. 15/406,329, filed on Jan. 13, 2017, granted, now 10,835,671.
Claims priority of provisional application 62/340,470, filed on May 23, 2016.
Claims priority of provisional application 62/278,978, filed on Jan. 14, 2016.
Prior Publication US 2021/0060245 A1, Mar. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/172 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/145 (2006.01); G16H 20/17 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); G16H 10/60 (2018.01); G16H 40/40 (2018.01); G16H 50/30 (2018.01)
CPC A61M 5/1723 (2013.01) [A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61M 5/142 (2013.01); A61M 5/14244 (2013.01); A61M 5/14248 (2013.01); A61M 5/145 (2013.01); G16H 20/17 (2018.01); G16H 40/60 (2018.01); G16H 40/67 (2018.01); A61B 2562/0295 (2013.01); A61M 2005/14208 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2230/005 (2013.01); A61M 2230/201 (2013.01); G16H 10/60 (2018.01); G16H 40/40 (2018.01); G16H 50/30 (2018.01)] 26 Claims
OG exemplary drawing
 
1. A method comprising:
determining to deliver insulin over a first diurnal time period according to a first baseline basal insulin rate of a schedule of baseline basal insulin rates;
based at least partially on received glucose data for a person with diabetes (PWD), delivering insulin during an occurrence of the first diurnal time period in an amount variable from an amount associated with the first baseline basal insulin rate; and
calculating an updated baseline basal insulin rate for a second diurnal time period such that a difference between the updated baseline basal insulin rate and an original, second baseline basal insulin rate associated with the second diurnal time period is less than a difference between the first baseline basal insulin rate stored for the first diurnal time period and a rate at which insulin was actually delivered during the first diurnal time period,
wherein the second diurnal time period is at least 20 hours after the occurrence of the first diurnal time period.